ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Trial of Poor Performance Status Patients (ToPPS)

ClinicalTrials.gov ID: NCT00892710

Public ClinicalTrials.gov record NCT00892710. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Phase II Trial of Pemetrexed vs. Pemetrexed/Bevacizumab vs. Pemetrexed/Carboplatin/Bevacizumab in Patients With Stage IIIB/IV Non-Small-Cell Lung Cancer and ECOG Performance Status 2

Study identification

NCT ID
NCT00892710
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
SCRI Development Innovations, LLC
Other
Enrollment
172 participants

Conditions and interventions

Interventions

  • Bevacizumab Drug
  • Carboplatin Drug
  • Pemetrexed Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2009
Primary completion
Jun 30, 2014
Completion
Apr 30, 2015
Last update posted
May 14, 2015

2009 – 2015

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
27
Facility City State ZIP Site status
Mayo Clinic - AZ Scottsdale Arizona 85259
Genesis Cancer Center Hot Springs Arkansas 71913
Northeast Arkansas Clinic Jonesboro Arkansas 72401
Wilshire Oncology Medical Group LaVerne California 91750
Aventura Medical Center Aventura Florida 33180
Collaborative Research Group/ Palm Beach Ins of Hem Onc Boynton Beach Florida 33435
Holy Cross Hospital Fort Lauderdale Florida 33308
Florida Cancer Specialists Fort Myers Florida 33901
Memorial Regional Cancer Center Hollywood Florida 33021
Watson Clinic Center for Cancer Care and Research Lakeland Florida 33805
Mount Sinai Comprehensive Cancer Center Miami Beach Florida 33140
Northeast Georgia Medical Center Gainesville Georgia 30501
University of Chicago Chicago Illinois 60637
Northern Indiana Cancer Research Consortium South Bend Indiana 46601
RHHP/ Hope Cancer Center Terra Haute Indiana 47802
Hematology Oncology Associates of Northern NJ Morristown New Jersey 07960
Oncology Hematology Care Cincinnati Ohio 45242
Toledo Community Oncology Program Toledo Ohio 43617
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232
Medical University of South Carolina Charleston South Carolina 29425
South Carolina Oncology Associates, PA Columbia South Carolina 29210
Spartanburg Regional Medical Center Spartanburg South Carolina 29303
Chattanooga Oncology Hematology Associates Chattanooga Tennessee 37404
Family Cancer Center Memphis Tennessee 38120
Tennessee Oncology, PLLC Nashville Tennessee 37023
The Center for Cancer and Blood Disorders Fort Worth Texas 76104
Virginia Cancer Institute Richmond Virginia 23235

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00892710, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2015 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00892710 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →